drugset / Trial / NCT03395860

Low Dose ATG Plus Low Dose PTCy as GVHD Prophylaxis in Haplo-HSCT

NCT03395860

RandomizedParallel-groupOpen-labelTreatment

Summary

Low dose Rabbit Antithymocyte Globulin plus Low-dose post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical hematopoietic stem cell transplantation for patients with hematologic malignancies

Timeline

Start
2017-05-30
Primary completion
2020-05-20
Completion
2021-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject ANTILYMPHOCYTE IMMUNOGLOBULIN (HORSE) Protein / enzyme biologic 2.5 mg/kg
Subject Cyclophosphamide Other / unclassified 50 mg/kg